This inventor holds 1 USPTO granted patent. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1980.
Company Filing History:
Years Active: 1980
Title: The Innovations of Wen C Liu
Introduction
Wen C Liu is a notable inventor based in Princeton Junction, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of substances that enhance the effectiveness of antibiotics. His work is characterized by a focus on innovative solutions to combat antibiotic resistance.
Latest Patents
Wen C Liu holds a patent for a substance known as EM4615, which is a .beta.-lactamase inhibitor. This substance inhibits the enzyme .beta.-lactamase, produced by a wide range of microorganisms. EM4615 is obtained when species of the microorganism Micromonospora are cultivated under aerobic fermentation conditions. The inhibitor can be isolated from the fermentation medium by extraction. This innovation is particularly useful in enhancing the effectiveness of .beta.-lactam antibiotics such as penicillins and cephalosporins.
Career Highlights
Wen C Liu is associated with E. R. Squibb Sons, Inc., where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of antibiotic mechanisms and improving treatment options for bacterial infections. With a focus on practical applications, Liu's research has the potential to impact public health significantly.
Collaborations
Wen C Liu has collaborated with notable colleagues, including J Scott Wells and Pacifico A Principe. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biochemistry.
Conclusion
Wen C Liu's contributions to the field of biochemistry, particularly through his patent for EM4615, highlight his role as an innovator in combating antibiotic resistance. His work continues to pave the way for advancements in medical treatments and public health.